Surgical treatment of benign mediastinal neurogenic tumors - a 7-year analysis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F20%3AN0000105" target="_blank" >RIV/00064190:_____/20:N0000105 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.14735/amcsnn2020184" target="_blank" >http://dx.doi.org/10.14735/amcsnn2020184</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14735/amcsnn2020184" target="_blank" >10.14735/amcsnn2020184</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Surgical treatment of benign mediastinal neurogenic tumors - a 7-year analysis

Popis výsledku v původním jazyce

Aim: Benign intrathoracic neurogenic tumors are neoplasms with low frequency prevalence ocurring predominantly in the posterior mediastinum. Video-assisted thoracoscopic surgery (VATS) enables minimally invasive surgical treatment in a number of intrathoracic diseases. The aim of this work was to compare the results of operations of neurogenic tumors of the mediastinum by VATS and open resection. Patients and methods: We retrospectively analyzed the set of 22 patients who underwent surgery between 2013-2018 for benign neurogenic tumors of the mediastinum. Results: The average age in the group was 57 years, 73% were women. 19 patients (86.4%) were asymptomatic and their tumors were accidental findings. Based on the histological examination 20 cases (90.9%) were neurinomas, 1 case (4.5%) was a paraganglion and 1 case (4.5.%) was a neurofibroma. There were no operative deaths in the group. Postoperative morbidity was 13.6%. VATS patients had significantly lower blood loss (42.5 +/- 52.6 vs. 95 +/- 48 mL; P = 0.033), shorter hospital stay (6.9 +/- 1.5 vs. 11 +/- 2.6 days; P = 0.008) and lower incidence of complications (6.25 vs. 33%; P = 0.001). There was no significant difference between the groups compared in the length of operations (78 +/- 22.3 vs. 87 +/- 72.2 min; P = 0.393) and tumor size (40 +/- 19.9 vs. 61 +/- 54.7 mm; P = 0.074). No tumor relapse occur red during the follow-up period (mean 34 months). Conclusion: VATS represents a safe and effective surgical method in the treatment of benign mediastinal tumors. Compared to open access, VATS achieved better results in lower blood loss, shorter hospital stay and lower frequency of complications.

Název v anglickém jazyce

Surgical treatment of benign mediastinal neurogenic tumors - a 7-year analysis

Popis výsledku anglicky

Aim: Benign intrathoracic neurogenic tumors are neoplasms with low frequency prevalence ocurring predominantly in the posterior mediastinum. Video-assisted thoracoscopic surgery (VATS) enables minimally invasive surgical treatment in a number of intrathoracic diseases. The aim of this work was to compare the results of operations of neurogenic tumors of the mediastinum by VATS and open resection. Patients and methods: We retrospectively analyzed the set of 22 patients who underwent surgery between 2013-2018 for benign neurogenic tumors of the mediastinum. Results: The average age in the group was 57 years, 73% were women. 19 patients (86.4%) were asymptomatic and their tumors were accidental findings. Based on the histological examination 20 cases (90.9%) were neurinomas, 1 case (4.5%) was a paraganglion and 1 case (4.5.%) was a neurofibroma. There were no operative deaths in the group. Postoperative morbidity was 13.6%. VATS patients had significantly lower blood loss (42.5 +/- 52.6 vs. 95 +/- 48 mL; P = 0.033), shorter hospital stay (6.9 +/- 1.5 vs. 11 +/- 2.6 days; P = 0.008) and lower incidence of complications (6.25 vs. 33%; P = 0.001). There was no significant difference between the groups compared in the length of operations (78 +/- 22.3 vs. 87 +/- 72.2 min; P = 0.393) and tumor size (40 +/- 19.9 vs. 61 +/- 54.7 mm; P = 0.074). No tumor relapse occur red during the follow-up period (mean 34 months). Conclusion: VATS represents a safe and effective surgical method in the treatment of benign mediastinal tumors. Compared to open access, VATS achieved better results in lower blood loss, shorter hospital stay and lower frequency of complications.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

ČESKÁ A SLOVENSKÁ NEUROLOGIE A NEUROCHIRURGIE

ISSN

1210-7859

e-ISSN

1802-4041

Svazek periodika

83

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

184-188

Kód UT WoS článku

000526056700011

EID výsledku v databázi Scopus

2-s2.0-85083584921